Close Menu

The Wall Street Journal's 2008 CEO compensation survey is out. Most of the pharma CEOs make in the $16 million to $18 million range, and the highest-paid person on the list of pharma execs is Abbott's Miles White, who receives a little more than $18 million. Eli Lilly's new CEO, John Lechleiter, may feel a little shafted with a compensation package worth about $10 million.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.